Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Landec Corporation LNDC
$8.76
На 18:00, 12 мая 2023
+48.40%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
263626944.00000000
-
week52high
12.04
-
week52low
7.65
-
Revenue
185786000
-
P/E TTM
-5
-
Beta
1.10228500
-
EPS
-2.17100000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 апр 2023 г. в 04:00
Описание компании
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, and filled products. In addition, it offers O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products. The company operates in the United States, Canada, and internationally. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Barrington Research | Outperform | Market Perform | 11 авг 2022 г. |
| Stephens & Co. | Overweight | 20 июл 2022 г. | |
| Barrington Research | Market Perform | Outperform | 06 апр 2022 г. |
| Roth Capital | Buy | Buy | 04 окт 2021 г. |
| Roth Capital | Buy | Buy | 30 июл 2021 г. |
| Barrington Research | Outperform | Outperform | 07 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | A | 2155694 | 147000 | 24 окт 2022 г. |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | A | 1627593 | 103000 | 24 окт 2022 г. |
| Hall James G | A | 45000 | 45000 | 11 авг 2022 г. |
| Hall James G | A | 150000 | 150000 | 11 авг 2022 г. |
| Morberg John D | A | 13500 | 13500 | 11 авг 2022 г. |
| Morberg John D | A | 13000 | 12591 | 11 авг 2022 г. |
| Morberg John D | A | 409 | 409 | 11 авг 2022 г. |
| Hall James G | D | 0 | 10000 | 05 авг 2022 г. |
| Hall James G | D | 51096 | 3060 | 05 авг 2022 г. |
| Hall James G | A | 54156 | 10000 | 05 авг 2022 г. |
Новостная лента
Landec Corporation (LNDC) Q1 2023 Earnings Call Transcript
Seeking Alpha
06 окт 2022 г. в 10:40
Landec Corporation (NASDAQ:LNDC ) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive Officer John Morberg - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Mark Smith - Lake Street Capital Markets Mike Petusky - Barrington Research Mitch Pinheiro - Sturdivant & Company Operator Good morning and thank you for joining Landec's Fiscal 2023 First Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode.
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
GlobeNewsWire
28 сент 2022 г. в 16:05
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced a change to its previously announced fiscal 2023 first quarter earnings conference call date in recognition of Yom Kippur.
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
GlobeNewsWire
21 сент 2022 г. в 08:00
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it will host a conference call to discuss fiscal 2023 first quarter financial results. The live webcast can be accessed via Landec's website on the Investor Events & Presentations page. The webcast will be available for 30 days.
7 Small-Cap Stocks to Buy Before September Ends
InvestorPlace
15 сент 2022 г. в 11:54
While broader markets face continued pressure amid recession fears, small-cap stocks stand out as an undervalued segment of the stock market. The Russell 2000 index, the popular benchmark for small-cap stocks, is currently down 18% over the past year.
7 Small-Cap Stocks to Buy Before September Ends
InvestorPlace
14 сент 2022 г. в 14:40
While broader markets face continued pressure amid recession fears, small-cap stocks stand out as an undervalued segment of the stock market. The Russell 2000 index, the popular benchmark for small-cap stocks, is currently down 18% over the past year.